Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK Cell Immunotherapy Maintenance in SCLC
NCT03410368Phase 2Unknown
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of autologous natural killer cells in small cell lung cancer (SCLC). Status: unknown.
02
Drugs
autologous natural killer cells
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03410368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410368.